Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Summary

This study evaluates the safety and diagnostic performance of 18F-DCFPyL Injection in patients with at least high risk prostate cancer who are planned for radical prostatectomy with lymphadenectomy (Cohort A) or in patients with locally recurrent or metastatic disease willing to undergo biopsy (Cohort B). Cohort B is complete and no longer recruiting subjects.

Timeline

Start

2016-11

Primary completion

2018-07

Completion

2018-07

Drugs

Indications